Quality Control Checkpoints in RNA Sample Prep: Beyond A260/A280

Team Dynamic Matrices | 22 February 2026

The A260/A280 ratio tells you less than you think

Open almost any RNA extraction protocol and you'll find the same sign-off step: measure absorbance at 260 nm and 280 nm on a NanoDrop, confirm the ratio sits near 2.0, and move on to library prep. It's fast, it's cheap, and it's been the default RNA quality gate for decades. It's also, on its own, a poor predictor of whether that RNA will actually perform well downstream.

The A260/A280 ratio measures one thing: the relative absorbance of nucleic acids versus protein. A clean ratio near 2.0 tells you the sample isn't heavily contaminated with protein or phenol carryover from extraction. It tells you nothing about whether the RNA is intact, whether genomic DNA is still present, whether ribosomal RNA dominates the pool, or whether inhibitors are riding along that will only show up once the sample hits a polymerase. A sample can pass A260/A280 cleanly and still fail catastrophically in RT-qPCR, RNA-seq, or long-read sequencing.

This gap matters because sample preparation failures rarely announce themselves early. A degraded or contaminated sample that clears a single spectrophotometric check can consume days of sequencing time and thousands of dollars in reagents before the problem surfaces in a failed library, a skewed count matrix, or an irreproducible qPCR curve. Treating A260/A280 as sufficient QC isn't wrong, exactly, it's just answering a much narrower question than most labs assume it is.

What A260/A280 actually misses

Degradation goes undetected

Absorbance ratios are agnostic to fragment length. A tube of RNA that has been partially degraded by residual RNase activity, freeze-thaw cycling, or prolonged room-temperature handling can still show a textbook 2.0 ratio, because degradation products still absorb at 260 nm in roughly the same proportion as intact transcripts. The spectrophotometer simply can't distinguish a population of full-length mRNAs from a population of short fragments that used to be full-length mRNAs.

This is precisely why RNA integrity has to be assessed separately, typically via capillary electrophoresis systems that generate an RNA Integrity Number (RIN) or equivalent RNA Quality Number (RQN). These systems examine the ratio and sharpness of 18S and 28S ribosomal RNA peaks as a proxy for overall sample integrity, producing a score from 1 (fully degraded) to 10 (intact). For most downstream applications, including standard RNA-seq and most qPCR assays, a RIN above 7 is the conventional threshold, though the right cutoff depends heavily on the application. Degradation tolerance for 3' end-counting protocols differs substantially from what's acceptable for full-length isoform sequencing.

Genomic DNA contamination hides in plain sight

Genomic DNA absorbs at 260 nm just like RNA does, and in small amounts it barely shifts an A260/A280 ratio at all. Yet even low-level gDNA carryover can be enough to generate false-positive signal in RT-qPCR assays targeting intronless genes, or to inflate background reads in RNA-seq libraries. Because gDNA and RNA are chemically similar enough to co-purify through many standard extraction chemistries, contamination is common and easy to miss with absorbance alone.

The more reliable check is a targeted qPCR assay run without reverse transcription, amplifying a genomic target directly from the "RNA" sample. Any amplification indicates DNA contamination that needs to be addressed with a DNase treatment step before proceeding. Fluorometric quantification methods that are nucleic-acid-specific (as opposed to UV absorbance, which can't discriminate DNA from RNA at all) are a useful complementary check here as well.

Concentration by absorbance overstates what you actually have

UV absorbance-based concentration estimates are notoriously sensitive to contaminants. Residual phenol, guanidine salts from extraction buffers, or even nucleotide monophosphates can inflate the apparent 260 nm signal, leading to concentration values that overstate true RNA content, sometimes significantly. Labs that plan library input based solely on NanoDrop concentration readings frequently find themselves under-loading reactions relative to what they intended, or wasting precious low-input samples on a poorly calibrated pipetting scheme.

Fluorescence-based quantification assays, which use dyes that intercalate specifically with RNA rather than measuring bulk UV absorbance, are considerably more accurate for concentration determination, particularly for low-input or precious samples where getting the input mass right the first time matters.

Ribosomal RNA load isn't visible in a ratio

For sequencing applications, one of the most consequential quality dimensions isn't captured by absorbance at all: how much of the total RNA pool is ribosomal RNA versus the messenger and non-coding RNA species researchers actually care about. Since rRNA typically makes up 80 to 90% of total cellular RNA, insufficient rRNA depletion or capture-based enrichment can quietly consume the majority of sequencing depth on uninformative reads, regardless of how "pure" the sample looked on a spectrophotometer. This checkpoint only becomes visible after library prep and sequencing, which is exactly why upstream enrichment chemistry matters so much before that point, not just extraction chemistry.

Building a real QC checkpoint system

A more robust RNA sample prep workflow treats quality control as a series of checkpoints rather than a single gate:

> Checkpoint 1, extraction output. Fluorometric concentration and a targeted gDNA qPCR check immediately after extraction, before any downstream processing begins. Catching contamination here is far cheaper than catching it after library construction.

> Checkpoint 2, integrity assessment. RIN/RQN scoring via capillary electrophoresis, run on a representative subset of samples at minimum, and on every precious or irreplaceable sample without exception. This is the checkpoint most likely to explain a downstream failure retroactively if skipped.

> Checkpoint 3, enrichment efficiency. For sequencing workflows, confirming rRNA depletion or target enrichment efficiency before committing full sequencing depth to a library. This is where the enrichment chemistry itself, the selectivity of pulldown or depletion reagents, has an outsized effect on data quality that no amount of upstream QC can fully compensate for.

> Checkpoint 4, library-level QC. Fragment size distribution and adapter dimer assessment post-library-prep, confirming that everything upstream translated into a usable sequencing library rather than assuming it did.

Each checkpoint answers a different failure mode. Skipping straight from extraction to sequencing on the strength of a single absorbance ratio means any of these failure modes can propagate undetected until the data comes back, at which point the cause is much harder to diagnose retroactively.

Where enrichment chemistry fits into QC

It's worth noting that many of the quality problems labs try to catch after the fact, such as off-target depletion inflating background, low-input samples losing signal to non-specific pulldown, or degraded RNA fragmenting further under harsh bead-based protocols, are partly a function of how gentle and selective the upstream capture or depletion chemistry is in the first place. Dynamic crosslinker-based selection methods, such as LASSO, are built specifically to reduce off-target capture during rRNA depletion or targeted enrichment, which means fewer of these problems need to be caught downstream because fewer of them occur upstream. Good QC and good chemistry aren't substitutes for each other, but a selective, native-condition capture step reduces how much QC has to compensate for.

The bottom line

A260/A280 remains a legitimate, useful first-pass check. It's fast, cheap, and catches gross contamination. But treating it as the only quality gate in an RNA sample prep workflow leaves degradation, gDNA contamination, inaccurate quantification, and rRNA over-representation all invisible until they surface downstream, usually at a much higher cost in time and reagents. A layered QC approach, combining fluorometric quantification, RIN scoring, targeted gDNA qPCR, and enrichment-efficiency checks, catches these failure modes where they're cheapest to fix: before the sequencer, not after.